Tectonic Therapeutic (TECX) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Powered by 
Analysis
Tectonic Therapeutic (TECX) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -35.50% |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 81.16% |
| 10 | Tectonic Therapeutic | 584.94 Mn | 584.94 Mn | - | -147.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -147.64% |
| Mar 31, 2025 | -11.86% |
| Jun 30, 2024 | 35.13% |
| Mar 31, 2024 | 27.00% |
| Dec 31, 2023 | 7.72% |
| Sep 30, 2023 | 17.27% |
| Jun 30, 2023 | 32.77% |
| Mar 31, 2022 | -30.37% |
| Jun 30, 2021 | 32.10% |
| Mar 31, 2021 | -21.53% |
| Sep 30, 2020 | -2.93% |